Prevention of Alzheimer´s Disease Research Grant (worldwide)
The “Prevention Pipeline” from the Alzheimer´s Drug Discovery Foundation provides funding for studies, including clinical trials, that examine whether the use or choice of drugs affects dementia or cognitive decline in three main focus areas:
- Studies of Cognitive Decline and Risk Reduction
- Comparative Effectiveness Research
- Studies Leveraging the Consortium of Cohorts for Alzheimer’s Prevention Action (CAPA)
Funding is available to researchers worldwide, at both non-profit research institutions as well as for-profit organizations. Applicants may apply for up to 3 million USD (direct costs only) for multi-year funding support. There are three assessment rounds per year and the next letter of intent is due September 30, 2022 and the full application is due on December 2, 2022.
Create or sign in to your free account for more functionalities, including a full display of the eligibility criteria such as location and citizenship requirements.